TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Top-line Final Data From Cantrixil Phase I Study Confirms Prior Positive Efficacy And Safety Signals

  • By PR Newswire
  • Dec 9, 2020 10:30 AM EST
PRESS RELEASES

Kazia Executes Agreement To Commence GBM Agile Pivotal Study

  • By PR Newswire
  • Oct 16, 2020 10:30 AM EDT
PRESS RELEASES

US FDA Grants Rare Pediatric Disease Designation (RPDD) To Paxalisib For DIPG

  • By PR Newswire
  • Aug 7, 2020 10:30 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.